Disease-modifying properties of long-term lithium treatment for amnestic mild cognitive impairment: randomised controlled trial.


BACKGROUND Two recent clinical studies support the feasibility of trials to evaluate the disease-modifying properties of lithium in Alzheimer's disease, although no benefits were obtained from short-term treatment. AIMS To evaluate the effect of long-term lithium treatment on cognitive and biological outcomes in people with amnestic mild cognitive… (More)
DOI: 10.1192/bjp.bp.110.080044

5 Figures and Tables


  • Presentations referencing similar topics